Search database
LIST OPTIONS
Filter
46
Filtered Results: 46
Text search: гепатит С
Featured
Language
Document type
No document type
19
Guidelines
17
Fact sheets
3
Manuals
2
Strategic & Response Plan
2
Studies & Reports
1
Resource Platforms
1
Videos
1
Countries / Regions
Russia
4
Ukraine
2
Armenia
2
Global
2
Eastern Europe
2
Tajikistan
1
Albania
1
Africa
1
Latin America and the Carribbean
1
South–East Asia Region
1
Argentina
1
South Africa
1
Moldova
1
Authors & Publishers
World Health Organization WHO
19
World Health Organization (WHO)
4
World Health Organisation (WHO)
3
World Health Organization
3
Organisation mondiale de la Santé (OMS)
2
A. Benzacar
1
A.Hill, T. Swan and K.Timmermans
1
Aftab Ala, Elizabeth Boxall, Steven Bradley et al.
1
Coordinación Nacional de Hepatitis Virales
1
EMTCT Global Validation Advisory Committee, Global HIV, Hepatitis and Sexually Transmitted Infections Programmes
1
European Association for the Study of the Liver
1
Flying Publisher, Boehringer Ingelheim
1
HelpNow
1
HIV i-BASE/TREATMENT ACTION GROUP
1
International AIDS society
1
Médecins Sans Frontières
1
Ministerio de Salud Argentina
1
MW Sonderup, Y Pillay et al.
1
National Clinical Guideline Centre
1
National Department of Health South Africa
1
OPS
1
Organización Mundial de la Salud OMS
1
Pan American Health Organisation PAHO
1
Pan American Health Organization (PAHO)
1
Pan American Health Organization PAHO
1
Polly Clayden, Simon Collins, Mike Frick, et al.
1
Spearman, CWN
1
Stefan Mauss, et al.
1
UNICEF
1
UNITAID
1
WHO, THE END TB STRATEGY
1
World Health Organization WHO
1
World Health Organization (WHO), Regional Office for South-East-Asia
1
Всемирная организация здравоохранения
1
Оганна Киракосян
1
Publication Years
Category
Hepatitis
42
Pediatrics
8
Gynaecology & Obstetrics
3
Paediatrics
2
Virology
2
Guidelines
2
HIV & STI
2
Communicable Diseases
1
Countries
1
Policies
1
Communicable Diseases
1
Maternal Health
1
TB
1
Toolboxes
Hepatitis
9
Paediatrics
3
Opportunistic Infections
2
Women
2
Prevention of mother-to-child transmission (PMTCT)
2
Eastern Europe & Central Asia
2
Drugs
1
TB & Drug Abuse
1
Adults
1
Ukraine
1
Prevention Guidelines
1
Policies
1
Transgender People
1
Men who have sex with men (MSM)
1
People who injecting Drugs
1
IEC Materials
1
HIV / AIDS
1
Universal Health Coverage UHC and 90-90-90 Strategy
1
Information, Resources & Websites
1
Armenia
1
Drug resistant TB
1
Co-Morbidities (except TB)
1
Substance Use Disorders & Addiction
1
HIV / AIDS
1
Clinical Guidelines
1
HIV in Key Populations
1
Prisoners
1
Презентация на тему значимости скрининга больных с лекарственно-устойчивым туберкулезом на гепатит С. Как лучше всего лечить этих пациентов от гепатита С.
ПЛАНИРОВАНИЕ И МОНИТОРИНГ ПРОГРЕССА НА ПУТИ К ЭЛИМИНАЦИИ
ПЛАНИРОВАНИЕ И МОНИТОРИНГ ПРОГРЕССА НА ПУТИ К ЭЛИМИНАЦИИ
В мае 2016 г. Всемирная ассамблея здравоохранения приняла первую Глобальную стратегию сектора здравоохранения (ГССЗ) по проблеме вирусных гепатитов. В ней б... more
Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection
Краткое содержание лекций семинара. На семинаре обсуждались ключевые проблемы в регионе, связанные с заболеваемостью ВИЧ, туберкулезом и гепатитом у людей, употре... more
В основе настоящих руководящих принципов лежит структура организации мероприятий в соответствии с тремя задачами: • создание и укрепление механизмов комплексно... more
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease. The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa... more
L’objectif des lignes directrices 2024 est de fournir des recommandations actualisées et fondées sur des données probantes sur les principaux sujets prioritaires. Ceux-ci concernent notamment les critères élargis et simplifiés de mise sous traitement pour les adultes, mais aussi désormais ... more
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig... more
Malgré les progrès récents vers la mise au point d’un traitement hautement efficace et abordable contre le virus de l’hépatite C, beaucoup de personnes infectées par ce virus ne connaissent pas leur statut. L’Organisation mondiale de la Santé (OMS) estime qu’en 2019, 58 millions ... more
The position papers are intended for use by national public health officials and managers of immunization programmes. They may also be of interest to international funding agencies, vaccine advisory groups, vaccine manufacturers, health professionals, researchers, the scientific media and the genera... more
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are: ... more
An overview of validation structures and responsibilities at national, regional and global levels. This governance document supplements the global guidance document. Validation of elimination requires rigorous assessment at the national, regional and global levels of the impact and process indicato... more
WHO’s Dr Philippa Easterbrook gives a situation update on the recent hepatitis outbreak affecting children including possible causes and steps parents, caregivers and countries should take.
The Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations outline a public health response for 5 key populations (men who have sex with men, trans and gender diverse people, sex workers, people who inject drugs and people in prisons and... more
The new treatment recommendations that extend the 2018 treat all recommendation for adults with chronic HCV infection to include adolescents and children down to 3 years, and to align the existing recommended pangenotypic direct-acting antiviral (DAA) regimens (SOF/DCV, SOF/VEL and G/P) for adults, ... more
Policy Brief. 24 June 2022. This policy brief, one of two on the updated hepatitis C (HCV) guidelines, focuses on the new recommendations on simplified service delivery for a public health approach to HCV testing, care and treatment. These recommendations include decentralization, integration and ta... more
Multiple countries are reporting severe acute cases of hepatitis of unknown aetiology in children, in several regions of the world. WHO has developed this clinical case report form (CRF) to support and facilitate reporting of anonymized, patient-level data of acute hepatitis of unknown aetiology.